Carbiotix, an innovative biotechnology company, has reported significant growth in its NutraCycle customer projects. CEO Erik Deaner expressed satisfaction with the addition of six new customers in Q2, maintaining an average of one new project per week over the past year. This growth is attributed to Carbiotix's focus on engaging with specific customer profiles and side-stream types, which offer greater potential.

With over 120 qualified leads and a target group exceeding 10,000, Carbiotix is strategically shifting its focus from attending trade shows to enhancing digital marketing efforts. This approach has proven to be more cost-effective in generating leads and conversions. The company has also developed comprehensive business cases that highlight the economic and sustainability benefits of evaluated side-streams, aiding in customer acquisition.

Carbiotix is observing several trends: the market remains in an early adopter phase, allowing the company to build relationships with key players. Additionally, there is a shift towards exploring Joint Development Agreement (JDA) projects directly, bypassing Pilot Pre-Studies. Carbiotix anticipates securing five JDAs in the latter half of 2025, signaling a promising future.

Given the company's strategic direction and market positioning, investors might consider a hold strategy. While the growth trajectory is positive, the company's focus on strategic customer engagement over sheer volume suggests a period of consolidation and relationship-building, which may not immediately translate into rapid financial gains.